Literature DB >> 9888452

Corneal transplantation in antibody-deficient hosts.

W R Goslings1, J Yamada, M R Dana, J W Streilein, E van Beelen, A P Prodeus, M C Carroll, M J Jager.   

Abstract

PURPOSE: To examine the role of donor-specific antibodies, with or without complement, in rejection of orthotopic corneal transplants by using mice as recipients in which the genes for the heavy chain of immunoglobulin or the third complement component have been eliminated by homologous recombination.
METHODS: BALB/c corneas were transplanted into eyes of B-cell-deficient (n=17) or wild-type control C57BL/6 (n=30) mice and into eyes of complement (C3)-deficient (n=15) or wild-type control 129-C57BL/6 (n=13) mice. After surgery all grafts were evaluated over 8 weeks in a masked manner by biomicroscopy for signs of rejection.
RESULTS: The rates of corneal transplant rejection were similar among B-cell-deficient and C3-deficient mice compared with rejection rates in their respective wild-type control subjects. This similarity applied to the time course of rejection and to cumulative survival rates.
CONCLUSIONS: Neither donor-specific antibody nor the third component of complement play essential roles in acute rejection of orthotopic corneal allografts in mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9888452

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Decay accelerating factor is essential for successful corneal engraftment.

Authors:  A Esposito; B Suedekum; J Liu; F An; J Lass; M G Strainic; F Lin; P Heeger; M E Medof
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

2.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 3.  Immunology and Donor-Specific Antibodies in Corneal Transplantation.

Authors:  Joanna Major; Bartosz Foroncewicz; Jacek Paweł Szaflik; Krzysztof Mucha
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-11-06       Impact factor: 4.291

4.  The role of cyclosporine and mycophenolate in an orthotopic porcine-to-rat corneal xenotransplantation.

Authors:  Hyeon Il Lee; Mee Kum Kim; Joo Youn Oh; Jung Hwa Ko; Hyun Ju Lee; Won Ryang Wee; Jin Hak Lee
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

Review 5.  Critical appraisal of loteprednol ointment, gel, and suspension in the treatment of postoperative inflammation and pain following ocular and corneal transplant surgery.

Authors:  Amir Pirouzian; E Randy Craven
Journal:  Clin Ophthalmol       Date:  2014-02-10

6.  Detection of Retinal Pigment Epithelium-Specific Antibody in iPSC-Derived Retinal Pigment Epithelium Transplantation Models.

Authors:  Sunao Sugita; Kenichi Makabe; Shota Fujii; Yuko Iwasaki; Hiroyuki Kamao; Takashi Shiina; Kazumasa Ogasawara; Masayo Takahashi
Journal:  Stem Cell Reports       Date:  2017-11-05       Impact factor: 7.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.